Abstract
BackgroundIbutilide is an action potential–prolonging antiarrhythmic currently in clinical trials. The drug shares structural similarities with E-4031 and dofetilide, specific blockers of the rapidly activating delayed rectifier K+current (IKr). However, previous in vitro studies in guinea pig myocytes have indicated that ibutilide does not block IKrbut rather increases a slow inward sodium current.Methods and ResultsIn this study, we compared the effects of ibutilide with those of dofetilide on outward current in mouse atrial tumor myocytes (AT-1 cells), a preparation in which, unlike guinea pig, a typical IKris the major delayed rectifier and can be readily recorded in isolation from other currents. In AT-1 cells, ibutilide and dofetilide were both potent IKrblockers, with EC50values of 20 (n=12) and 12 (n=8) nmol/L, respectively, at +20 mV. The time and voltage dependence of IKrinhibition by the two compounds were virtually identical. The following characteristics were most consistent with open channel block: (1) block increased with depolarizing pulses; (2) block increased with longer pulses; (3) currents deactivated more slowly in the presence of drug, resulting in a “crossover” typical of open channel block; and (4) with repetitive pulsing after drug wash-in, use-dependent block was observed.ConclusionsThese data suggest that the clinical actions of ibutilide are mediated at least in part by block of IKr; an effect on inward currents is not excluded. AT-1 cells are a useful model system for the study of drug block of this important repolarizing current.
References
35
Referenced
150
10.1161/circ.82.6.2242545
10.1016/0002-9149(93)90236-6
-
Singh BN. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. Eur Heart J. 1993;14(suppl H):14-23.
(
10.1093/eurheartj/14.suppl_H.14
) 10.1085/jgp.96.1.195
10.1161/circ.82.1.2114236
-
Carmeliet E. Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther. 1992;262:809-817.
(
10.1016/S0022-3565(25)10827-6
) / J Pharmacol Exp Ther (1992) 10.1161/res.75.5.7923633
10.1126/science.2964082
- Steinhelper ME, Lanson NA Jr, Dresdner KP, Delcarpio JB, Wit AL, Claycomb WC, Field LJ. Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am J Physiol. 1990;259:H1826-H1834. / Am J Physiol (1990)
10.1161/res.69.6.1954678
10.1016/0014-2999(92)90467-I
- Buchanan LV, Kabell G, Brunden MN, Gibson JK. Comparative assessment of ibutilide, d-sotalol, clofilium, E-4031 and UK-68,798 in a rabbit model of proarrhythmia. J Cardiovasc Pharmacol. 1993;22:540-549. / J Cardiovasc Pharmacol (1993)
- DiMarco JP, The Ibutilide for Atrial Arrhythmias Study Group. Cardioversion of atrial flutter by intravenous ibutilide, a new class III antiarrhythmic agent. J Am Coll Cardiol. 1991;17:324A. Abstract. / J Am Coll Cardiol (1991)
-
Lee KS. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. J Pharmacol Exp Ther. 1992;262:99-108.
(
10.1016/S0022-3565(25)10779-9
) / J Pharmacol Exp Ther (1992) 10.1007/BF00656997
10.1007/BF00582522
10.1126/science.2543073
10.1113/jphysiol.1987.sp016571
10.1085/jgp.96.4.835
-
Snyders DJ, Knoth KM, Roberds SL, Tamkun MM. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol. 1992;41:322-330.
(
10.1016/S0026-895X(25)08880-7
) / Mol Pharmacol (1992) 10.1016/0014-2999(93)90704-L
- Wesley RC Jr, Farkhani F, Morgan D, Zimmerman D. Ibutilide: enhanced defibrillation via plateau sodium current activation. Am J Physiol. 1993;264:H1269-H1274. / Am J Physiol (1993)
10.1161/01.RES.72.1.75
10.1161/res.68.1.1984874
-
Lynch JJ Jr, Wallace AA, Van der Gaag LH, Baskin EP, Bear CM, Gehret JR, Kothstein T, Stupienski RF, Appleby SD, Sanguinetti MC. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1′-[2-(benzofurazan-5-yl)ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4′-piperidin]-4-one HCl (L-691,121), a novel class III agent. J Pharmacol Exp Ther. 1993;265:720-730.
(
10.1016/S0022-3565(25)38200-5
) / J Pharmacol Exp Ther (1993) -
Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther. 1985;232:817-825.
(
10.1016/S0022-3565(25)20919-3
) / J Pharmacol Exp Ther (1985) 10.1161/circ.79.5.2469545
10.1097/00005344-199008000-00019
10.1016/S0735-1097(87)80389-3
- Echt DS Lee JT Murray KT Vorperian V Borganelli SM Crawford DM Roden DM. A randomized double-blind placebo-controlled dose-ranging study of intravenous UK-68 798 (dofetilide) in patients with inducible sustained ventricular tachyarrhythmias. Circulation. 1991;84(suppl II):II-714. Abstract.
10.1016/0002-8703(93)90726-P
- Hohnloser SH, Arendts W, Quart B, Bristol Myers Squibb Research Institute. Incidence, type, and dose-dependence of proarrhythmic events during sotalol therapy in patients treated for sustained VT/VF. PACE Pacing Clin Electrophysiol. 1992;15:551. Abstract. / PACE Pacing Clin Electrophysiol (1992)
10.1016/0002-9149(92)91306-O
- Sanguinetti MC, Jurkiewicz NK. Lanthanum blocks a specific component of IK and screens membrane surface change in cardiac cells. Am J Physiol. 1990;259:H1881-H1889. / Am J Physiol (1990)
10.1161/res.69.2.1860189
Dates
Type | When |
---|---|
Created | 13 years, 2 months ago (June 11, 2012, 8:34 p.m.) |
Deposited | 5 months ago (March 30, 2025, 4:51 p.m.) |
Indexed | 1 month, 4 weeks ago (July 6, 2025, 1:45 p.m.) |
Issued | 30 years, 5 months ago (March 15, 1995) |
Published | 30 years, 5 months ago (March 15, 1995) |
Published Print | 30 years, 5 months ago (March 15, 1995) |
@article{Yang_1995, title={Ibutilide, a Methanesulfonanilide Antiarrhythmic, Is a Potent Blocker of the Rapidly Activating Delayed Rectifier K+Current (IKr) in AT-1 Cells: Concentration-, Time-, Voltage-, and Use-Dependent Effects}, volume={91}, ISSN={1524-4539}, url={http://dx.doi.org/10.1161/01.cir.91.6.1799}, DOI={10.1161/01.cir.91.6.1799}, number={6}, journal={Circulation}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Yang, Tao and Snyders, Dirk J. and Roden, Dan M.}, year={1995}, month=mar, pages={1799–1806} }